Regenxbio reported promising interim data from a phase 1 trial of its gene therapy for wet age-related macular degeneration (AMD). The treatment, designed to…
Akouos has raised $50 million to take a gene therapy treatment for hearing loss into the clinic. The Boston-based biotech unveiled the series A round alongside…
Boehringer Ingelheim has secured the option to license a cystic fibrosis gene therapy. The agreement will see Boehringer work with British academics and Oxford…
Regeneron and Bluebird bio have teamed up to develop anti-cancer cell therapies. The collaboration combines Regeneron’s antibody expertise with Bluebird’s cell…
ITN Contributing Editor Greg Freiherr interviews Eliot Siegel, M.D., radiology professor at the University of Maryland School of Medicine and chief of Imaging…
Children with autism spectrum conditions often have trouble recognizing the emotional states of people around them — distinguishing a happy face from a fearful…